{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:27:34Z","timestamp":1792315654132,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.janxdis.2023.102805","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T11:40:06Z","timestamp":1701690006000},"page":"102805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Predictors of clinical worsening during a discontinuation trial of serotonin reuptake inhibitors for obsessive compulsive disorder"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7559-3064","authenticated-orcid":false,"given":"Jeremy","family":"Tyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Wheaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella E.","family":"Hamlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Rosenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen B.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna B.","family":"Foa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.janxdis.2023.102805_bib1","first-page":"358","article-title":"Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials","author":"Batelaan","year":"2017","journal-title":"bmj"},{"issue":"3","key":"10.1016\/j.janxdis.2023.102805_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0887-6185(97)00011-X","article-title":"Beliefs about worry and intrusions: The Meta-Cognitions Questionnaire and its correlates","volume":"11","author":"Cartwright-Hatton","year":"1997","journal-title":"Journal of Anxiety Disorders"},{"issue":"2","key":"10.1016\/j.janxdis.2023.102805_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000371865","article-title":"New classification of selective serotonin reuptake inhibitor withdrawal","volume":"84","author":"Chouinard","year":"2015","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"8","key":"10.1016\/j.janxdis.2023.102805_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.67","article-title":"Mechanisms of estradiol in fear circuitry: implications for sex differences in psychopathology","volume":"4","author":"Cover","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2003.09.010","article-title":"Insight in obsessive compulsive disorder and body dysmorphic disorder","volume":"45","author":"Eisen","year":"2004","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2023.102805_bib6","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.janxdis.2023.102805_bib7","doi-asserted-by":"crossref","unstructured":"First, M., Spitzer, R., Gibbon, M., & Williams, J. (1995). Structured clinical interview for DSM-IV axis I disorders-Patient edition (SCID-I\/P, Version 2.0). Biometrics Res Dep New York State Psychiatr Inst.","DOI":"10.1037\/t07827-000"},{"issue":"7","key":"10.1016\/j.janxdis.2023.102805_bib8","doi-asserted-by":"crossref","first-page":"21639","DOI":"10.4088\/JCP.12m07789","article-title":"Treatment response, symptom remission, and wellness in obsessive-compulsive disorder","volume":"74","author":"Farris","year":"2013","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2023.102805_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.3997","article-title":"A randomized controlled trial to test if medicated patients with obsessive compulsive disorder can discontinue medication after exposure\/response prevention augmentation","author":"Foa","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.janxdis.2023.102805_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/mp.2015.88","article-title":"Neural signatures of human fear conditioning: An updated and extended meta-analysis of fMRI studies","volume":"21","author":"Fullana","year":"2016","journal-title":"Molecular Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2023.102805_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2023.102805_bib12","unstructured":"Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"issue":"4","key":"10.1016\/j.janxdis.2023.102805_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"The British Journal of Social and Clinical Psychology"},{"issue":"6","key":"10.1016\/j.janxdis.2023.102805_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Horowitz","year":"2019","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.janxdis.2023.102805_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00737-015-0542-z","article-title":"Obsessive-compulsive disorder in pregnancy and the postpartum period: course of illness and obstetrical outcome","volume":"19","author":"House","year":"2016","journal-title":"Archives of women's mental health"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/10485252.2017.1404598","article-title":"Multiple predicting K-fold cross-validation for model selection","volume":"30","author":"Jung","year":"2018","journal-title":"Journal of Nonparametric Statistics"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000453664","article-title":"Effect of gonadal hormones on neurotransmitters implicated in the pathophysiology of obsessive-compulsive disorder: a critical review","volume":"105","author":"Karpinski","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1176\/appi.ajp.159.1.88","article-title":"Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder","volume":"159","author":"Koran","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2023.102805_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1467-9280.2009.02280.x","article-title":"Genetic gating of human fear learning and extinction: Possible implications for gene-environment interaction in anxiety disorder","volume":"20","author":"Lonsdorf","year":"2009","journal-title":"Psychological Science"},{"issue":"12","key":"10.1016\/j.janxdis.2023.102805_bib20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1017\/S0033291710000620","article-title":"Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive\u2013compulsive disorder","volume":"40","author":"Maher","year":"2010","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib21","article-title":"The Arizona Sexual Experience Scale (ASEX): Reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"Journal of Sex & Marital Therapy"},{"key":"10.1016\/j.janxdis.2023.102805_bib22","first-page":"63","article-title":"Fear extinction as a model for translational neuroscience: Ten years of progress","author":"Milad","year":"2012","journal-title":"Annual Review of Psychology"},{"issue":"9","key":"10.1016\/j.janxdis.2023.102805_bib23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.biopsych.2007.08.016","article-title":"Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis","volume":"63","author":"Munaf\u00f2","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpsychires.2012.08.020","article-title":"Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators","volume":"47","author":"Olatunji","year":"2013","journal-title":"Journal of Psychiatric Research"},{"issue":"11","key":"10.1016\/j.janxdis.2023.102805_bib25","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00213-020-05630-9","article-title":"Metacognitive beliefs predict early response to pharmacological treatment in patients with obsessive\u2013compulsive disorder","volume":"237","author":"Park","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.janxdis.2023.102805_bib26","unstructured":"Pato, M.T., Zohar-Kadouch, R., Zohar, J., & Murphy, D.L. (1988). Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. The American journal of psychiatry."},{"key":"10.1016\/j.janxdis.2023.102805_bib27","doi-asserted-by":"crossref","unstructured":"Pinto, A., Ansell, E., & Wright, A. (2011). A new approach to the assessment of obsessive compulsive personality. Integrated paper session conducted at the annual meeting of the Society for Personality Assessment, Cambridge, MA. push.","DOI":"10.1037\/t73596-000"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-021-03038-z","article-title":"Sleep disturbances in obsessive-compulsive disorder: Influence of depression symptoms and trait anxiety","volume":"21","author":"Segal\u00e0s","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.janxdis.2023.102805_bib29","first-page":"266","article-title":"Insomnia in obsessive-compulsive disorder: A Swedish population-based cohort study","author":"Sevilla-Cerme\u00f1o","year":"2020","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.janxdis.2023.102805_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2021.103890","article-title":"Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder","volume":"143","author":"Simpson","year":"2021","journal-title":"Behaviour Research and Therapy"},{"issue":"5967","key":"10.1016\/j.janxdis.2023.102805_bib31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.1181886","article-title":"A genetic variant BDNF polymorphism alters extinction learning in both mouse and human","volume":"327","author":"Soliman","year":"2010","journal-title":"Science (New York, N York )"},{"issue":"1","key":"10.1016\/j.janxdis.2023.102805_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpsychires.2014.06.021","article-title":"Obsessive compulsive symptoms and sleep difficulties: Exploring the unique relationship between insomnia and obsessions","volume":"57","author":"Timpano","year":"2014","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.janxdis.2023.102805_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/01.yic.0000199454.62423.99","article-title":"Female hormones affect symptom severity in obsessive-compulsive disorder","volume":"21","author":"Vulink","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.janxdis.2023.102805_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0005-7967(03)00147-5","article-title":"A short form of the metacognitions questionnaire: Properties of the MCQ-30","volume":"42","author":"Wells","year":"2004","journal-title":"Behaviour Research and Therapy"},{"issue":"5","key":"10.1016\/j.janxdis.2023.102805_bib35","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/ccp0000025","article-title":"Augmenting serotonin reuptake inhibitors in obsessive\u2013compulsive disorder: What moderates improvement?","volume":"83","author":"Wheaton","year":"2015","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"7","key":"10.1016\/j.janxdis.2023.102805_bib36","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.4088\/JCP.v58n0709","article-title":"Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum","volume":"58","author":"Williams","year":"1997","journal-title":"The Journal of Clinical Psychiatry"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618523001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618523001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:11Z","timestamp":1760138291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618523001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"alternative-id":["S0887618523001433"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2023.102805","relation":{},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of clinical worsening during a discontinuation trial of serotonin reuptake inhibitors for obsessive compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2023.102805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102805"}}